Dublin, Aug. 12, 2022 (GLOBE NEWSWIRE) -- The "Medical Aesthetic Devices Market Size By Type, By Application, By End-use, and By Region Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. The global medical aesthetic devices market size is expected to reach USD 34.54 Billion in 2030 and register a revenue CAGR of 11.08% over the forecast period, according to latest report. Increasing awareness about physical appearance is estimated to be a key factor driving the market growth. Continuously increasing Research & Development (R&D) investments and expansions by key market players are projected to fuel the growth of the global medical aesthetics devices market over the forecast period (2021-2030). For instance, in October 2019, Allergan plc., a leading player in the medical aesthetics devices industry announced that it will expand its R&D facility in Westport, Ireland. The company is expected to invest approximately USD 160 million towards the expansion of this facility. This investment is projected to create around 200 new jobs in the country. Furthermore, in 2017, Solta Medical Inc., another major player in this industry announced that it will expand its R&D and operations facilities at its headquarters in Hayward, California. Medical aesthetic devices are used for improving the appearance of a person without performing surgery. These devices are also known as cosmetic surgery devices and comprise a wide range of products such as laser hair removal devices, microdermabrasion devices, photo rejuvenation systems, cellulite reduction devices, body contouring devices, breast implants, and others. Negative perceptions of aesthetic procedures as indulgent and unnecessary have been a restraint for the medical aesthetic devices market. However, with changing lifestyles and an increase in the number of working women, the demand for minimally invasive and non-invasive aesthetic procedures has increased globally. Some Key Highlights from the Report

Facial aesthetic procedures segment accounted for a significant revenue share in 2021 due to the rising demand for minimally invasive cosmetic procedures. The factors such as the increase in the number of working individuals and the awareness about physical appearance are expected to drive the segment growth over the forecast period.

Hospitals segment accounted for a significant revenue share in 2021 due to the rising number of cosmetic procedures performed in hospitals. The outpatient department (OPD) & clinics segment is also expected to grow at a rapid pace in the next few years. Medical aesthetic devices are used for hair removal, skin tightening, fat reduction, body contouring, tattoo removal, and other cosmetic procedures.

The APAC medical aesthetic devices market is projected to expand at a high rate during the forecast period. The region is expected to be a major contributor to the global market due to the presence of key manufacturers such as NEC Corporation, Syneron Medical Ltd., and Cynosure, Inc. in the region. The rising number of cosmetic procedures, growing awareness about the benefits of aesthetic treatments, and the availability of advanced technologies are some of the major factors expected to drive the market in APAC during the forecast period.

The medical aesthetic devices market in MEA is expected to expand at a moderate rate during the forecast period. The region is expected to be a major contributor to the global market due to the presence of key manufacturers such as Alma Lasers, Ltd. and Venus Concept Inc. in the region. The rising number of cosmetic procedures, growing awareness about the benefits of aesthetic treatments, and the availability of advanced technologies are some of the major factors expected to drive the market in MEA during the forecast period.

Some major companies in the global market report include Allergan Aesthetics, Alma Lasers, Anika Therapeutics, Inc. Cutera, Cynosure, El.En. S.p.A, Mentor Worldwide LLC, Merz Pharmaceuticals, LLC, Fontona, and GALDERMA Laboratories, L.P.

Key Topics Covered: Chapter 1. Market Synopsis Chapter 2. Executive Summary Chapter 3. Indicative Metrics Chapter 4. Medical Aesthetics Devices Market Segmentation & Impact Analysis 4.1. Medical Aesthetics Devices Market Material Segmentation Analysis 4.2. Industrial Outlook 4.2.1. Market indicators analysis 4.2.2. Market drivers analysis 4.2.2.1. Increasing demand of minimally invasive treatments 4.2.2.2. Growing population aged between 25 and 65 years 4.2.3. Market restraints analysis 4.2.3.1. Lack of reimbursement coverage 4.2.3.2. Stringent regulatory framework 4.3. Technological Insights 4.4. Regulatory Framework 4.5. Price trend Analysis 4.6. Customer Mapping 4.7. COVID-19 Impact Analysis 4.8. Global Recession Influence Chapter 5. Medical Aesthetics Devices Market By Type Insights & Trends 5.1. Type Dynamics & Market Share, 2022 & 2030 5.2. Energy-Based 5.2.1.1. Market estimates and forecast, 2019 - 2030 (USD Million) 5.2.1.2. Market estimates and forecast, by region, 2019 - 2030 (USD Million) 5.2.2. Laser-based 5.2.2.1. Market estimates and forecast, 2019 - 2030 (USD Billion) 5.2.2.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion) 5.2.3. Radiofrequency-based 5.2.3.1. Market estimates and forecast, 2019 - 2030 (USD Billion) 5.2.3.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion) 5.2.4. Light-based 5.2.4.1. Market estimates and forecast, 2019 - 2030 (USD Billion) 5.2.4.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion) 5.2.5. Ultrasound 5.2.5.1. Market estimates and forecast, 2019 - 2030 (USD Billion) 5.2.5.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion) 5.2.6. Others 5.2.6.1. Market estimates and forecast, 2019 - 2030 (USD Billion) 5.2.6.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion) 5.3. Non-energy Based 5.3.1.1. Market estimates and forecast, 2019 - 2030 (USD Million) 5.3.1.2. Market estimates and forecast, by region, 2019 - 2030 (USD Million) 5.3.2. Botulinum Toxin 5.3.2.1. Market estimates and forecast, 2019 - 2030 (USD Billion) 5.3.2.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion) 5.3.3. Dermal Fillers and Aesthetic Threads 5.3.3.1. Market estimates and forecast, 2019 - 2030 (USD Billion) 5.3.3.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion) 5.3.4. Microdermabrasion 5.3.4.1. Market estimates and forecast, 2019 - 2030 (USD Billion) 5.3.4.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion) 5.3.5. Implants 5.3.5.1. Market estimates and forecast, 2019 - 2030 (USD Billion) 5.3.5.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion) 5.3.6. Others 5.3.6.1. Market estimates and forecast, 2019 - 2030 (USD Billion) 5.3.6.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion) Chapter 6. Medical Aesthetics Devices Market By Application Insights & Trends 6.1. Application Dynamics & Market Share, 2022 & 2030 6.2. Skin Resurfacing and Tightening 6.2.1. Market estimates and forecast, 2019 - 2030 (USD Billion) 6.2.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion) 6.3. Body Contouring 6.3.1. Market estimates and forecast, 2019 - 2030 (USD Billion) 6.3.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion) 6.4. Cellulite Reduction 6.4.1. Market estimates and forecast, 2019 - 2030 (USD Billion) 6.4.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion) 6.5. Hair Removal 6.5.1. Market estimates and forecast, 2019 - 2030 (USD Billion) 6.5.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion) 6.6. Facial Aesthetic Procedures 6.6.1. Market estimates and forecast, 2019 - 2030 (USD Billion) 6.6.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion) 6.7. Breast Augmentation 6.7.1. Market estimates and forecast, 2019 - 2030 (USD Billion) 6.7.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion) 6.8. Others 6.8.1. Market estimates and forecast, 2019 - 2030 (USD Billion) 6.8.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion) Chapter 7. Medical Aesthetics Devices Market By End-use Insights & Trends 7.1. End-use Dynamics & Market Share, 2022 & 2030 7.2. Clinics 7.2.1. Market estimates and forecast, 2019 - 2030 (USD Billion) 7.2.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion) 7.3. Hospitals 7.3.1. Market estimates and forecast, 2019 - 2030 (USD Billion) 7.3.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion) 7.4. Home settings 7.4.1. Market estimates and forecast, 2019 - 2030 (USD Billion) 7.4.2. Market estimates and forecast, By Region, 2019 - 2030 (USD Billion) Chapter 8. Medical Aesthetics Devices Market Regional Outlook Chapter 9. Competitive Landscape 9.1. Market Revenue Share by Manufacturers 9.2. Manufacturing Cost Breakdown Analysis 9.3. Mergers & Acquisitions 9.4. Market positioning 9.5. Strategy Benchmarking 9.6. Vendor Landscape Chapter 10. Company Profiles 10.1. Allergan Aesthetics 10.1.1. Company Overview 10.1.2. Financial Performance 10.1.3. Technology Insights 10.1.4. Strategic Initiatives 10.2. Alma Lasers 10.2.1. Company Overview 10.2.2. Financial Performance 10.2.3. Technology Insights 10.2.4. Strategic Initiatives 10.3. Anika Therapeutics, Inc. 10.3.1. Company Overview 10.3.2. Financial Performance 10.3.3. Technology Insights 10.3.4. Strategic Initiatives 10.4. Cutera 10.4.1. Company Overview 10.4.2. Financial Performance 10.4.3. Technology Insights 10.4.4. Strategic Initiatives 10.5. Cynosure 10.5.1. Company Overview 10.5.2. Financial Performance 10.5.3. Technology Insights 10.5.4. Strategic Initiatives 10.6. El.En. S.p.A. 10.6.1. Company Overview 10.6.2. Financial Performance 10.6.3. Technology Insights 10.6.4. Strategic Initiatives 10.7. Mentor Worldwide LLC 10.7.1. Company Overview 10.7.2. Financial Performance 10.7.3. Technology Insights 10.7.4. Strategic Initiatives 10.8. Merz Pharmaceuticals, LLC. 10.8.1. Company Overview 10.8.2. Financial Performance 10.8.3. Technology Insights 10.8.4. Strategic Initiatives 10.9. Fontona 10.9.1. Company Overview 10.9.2. Financial Performance 10.9.3. Technology Insights 10.9.4. Strategic Initiatives 10.10. GALDERMA Laboratories, L.P. 10.10.1. Company Overview 10.10.2. Financial Performance 10.10.3. Technology Insights 10.10.4. Strategic Initiatives For more information about this report visit https://www.researchandmarkets.com/r/vukcku

The entrepreneur Mark Cuban just took a stand in a debate that's hotly controversial in business circles and Congress.

Three state-owned Chinese corporate giants announced plans Friday to remove their shares from the New York Stock Exchange, adding to a growing financial separation between the biggest global economies in the midst of a dispute over scrutiny of company audits.

Inflation is still near multi-decade highs. Mr. Wonderful is using these stocks to fight back.

The super investor sees softness. But is sticking to her guns.

These are the top trending tickers on Yahoo Finance after-hours on Aug. 12.

Inflation has been making headlines all year, and rightly so; it’s at 40-year high levels, driven by sharp increases in the prices of gasoline and diesel fuels. But oil and its various refined products have come down in recent weeks, and so – the July inflation numbers weren’t as bad as had been feared. The overall year-over-year price increase for the month came to 8.5%, still awful, but less than the 8.7% economists had been predicting. Markets these days are rallying in response. Whether this

In this article, we talk about 11 best falling stocks to buy now. If you wish to skip our detailed analysis of the latest market situation, go directly to 5 Best Falling Stocks To Buy Now. After a brutal 2022 which saw the S&P500 shed more than 21% in the first half of the year, Q2 […]

Tesla has given investors something to look forward to this coming week: a three-for-one stock split. As of the close of trading on Aug. 24, Tesla shareholders will get a “dividend” of two extra shares. The next day, Tesla stock will start trading at the new price—a third of what it used to be.

Profit warnings from Nvidia and Micron have sent a chill through chip stocks, but the long-term opportunity is still intact.

Five Chinese state-owned companies said they intend to delist their American depositary shares from the New York Stock Exchange, as financial regulators in Beijing and Washington remain at loggerheads over U.S. audit requirements. In separate filings to Hong Kong’s stock exchange Friday, PetroChina , China Petroleum & Chemical , Aluminum Corp. of China , China Life Insurance Co ,  and Sinopec Shanghai Petrochemical Co said they have notified the NYSE that they plan to voluntarily delist their American depositary shares.

Johnson & Johnson stock is hitting its lowest level since March. Here's where it's a steal of a deal.

(Bloomberg) -- Principal Global Investors’ Seema Shah is no stock market bull but says the rally that erupted Wednesday may continue until the head of the Federal Reserve steps up and stops it.Most Read from BloombergStriking Drop in Stress Hormone Predicts Long Covid in StudyThe Fed’s Damage to the Housing Market May Last YearsGarland Seeks to Unseal Trump Warrant, Says He Approved SearchChina Has Painted Itself Into a Semiconductor CornerRuto, Odinga Shy of Victory in Latest Vote Counts: Kenya

For the first half of 2022, the S&P 500 fell 20.6%, its worst showing since 1970. The U.S. inflation rate for June was 9.1%. Economists are looking for it to go even higher in the months ahead. At the end of July, the Federal Reserve hiked its Fed Funds rate 75 basis points, the second consecutive time it’s done so. The benchmark Fed Funds rate is what the Federal Reserve charges banks for overnight borrowing. On top of that, a blowout nonfarm payroll jobs report for June showed an increase of 5

The board of Devon Energy Corporation ( NYSE:DVN ) has announced that it will be paying its dividend of $1.55 on the...

The S&P 500’s initial surge on Thursday to fresh three-month highs fizzled as the session wore on. The good news for bulls is that this is a Tom Jones rally, as in his famous song: “It’s not unusual.” Specifically, there is nothing superlative about the market’s, notably the Nasdaq’s, resurgence off its mid-June trough, suggests Bespoke Investment Group.

After a 3.3% weekly gain, the S&P 500 is down just 10% for the year. Stocks could keep rising if the Fed shows restraint from here.

Marathon Digital Holdings, Inc. ( NASDAQ:MARA ) just released its latest quarterly report and things are not looking...

Yahoo Finance Live looks at several Chinese stocks reportedly scheduled to de-list from the NYSE.

Yahoo Finance reporter Pras Subramanian discusses Rivian shares being volatile after its disappointing second-quarter earnings results.

The process of dealing with a delisted stock is painful for individual investors and impossible for many institutional investors.